Experimentica

Experimentica is a contract research organization (CRO) that provides preclinical ocular models and study services. Its offering includes in vitro permeability and toxicity testing on corneal and retinal pigment epithelium cells, electroretinography, in vivo imaging, AI-based image analysis, tissue processing, histological staining and immunohistochemistry. It also runs validated disease models, including diabetic retinopathy, oxygen-induced retinopathy, laser-induced choroidal neovascularization, dry eye and microbead-induced glaucoma.

Its customers are pharmaceutical, biotech and academic clients working in ophthalmic research and drug development, in North America, Europe and Asia-Pacific. The company sells preclinical study design and research services, and is establishing a GLP-compliant test facility for regulated safety and toxicology studies.

Experimentica was established in 2013 and is headquartered in Kuopio, Finland. It has laboratories in Finland and Lithuania and a business development office in France, and employs approximately 50 specialists. All its facilities are AAALAC accredited. The company accepts open applications for research, administration, operations and regulatory roles.

Product: Preclinical ocular models and study services, including in vitro permeability and toxicity assays, electroretinography, in vivo imaging and histology.